Cleared Traditional

MEDCORP FLOW I.V. REGULATOR EXTENSION SET (K971004) - FDA 510(k) Clearance

Class II General Hospital device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K971004 · Medcorp Intl. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1997
Decision
197d
Days
Class 2
Risk

K971004 is an FDA 510(k) clearance for the MEDCORP FLOW I.V. REGULATOR EXTENSION SET. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Medcorp Intl. (Laguna Hills, US). The FDA issued a Cleared decision on October 2, 1997 after a review of 197 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Medcorp Intl. devices

Submission Details

510(k) Number K971004 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 19, 1997
Decision Date October 02, 1997
Days to Decision 197 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
68d slower than avg
Panel avg: 129d · This submission: 197d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 234
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K971004.
SOLUTION ADMINISTRATION SET WITH CAPPED LUER ACTIVATED VALVE
K974571 · Baxter Healthcare Corp · May 1998
DUAL LUER LOCK CAP
K981318 · Baxter Healthcare Corp · Apr 1998
V3 VALVE
K974145 · B.Braun Medical, Inc. · Jan 1998
CONTINU-FLO SOLUTION SET
K971701 · Baxter Healthcare Corp · Jun 1997
GORE IRRIGATION SET
K964067 · W.L. Gore & Associates, Inc. · Jun 1997
INTERLINK MICRO-INFUSION MANIFOLD EXTENSION SETS
K970438 · Baxter Healthcare Corp · Apr 1997